Word

ANGICYTE

Status

Pending

Status Code

630

Status Date

Thursday, July 4, 2024

Serial Number

79399244

Mark Type

4

Filing Date

Monday, March 4, 2024

Trademark Owner History

VASCVERSA LIMITED

Classifications

5 Pharmaceuticals; drugs for medical purposes; stem cells; pharmaceutical preparations containing stem cells; stem cells for medical purposes; cells for medical use; cell growth media for growing cells for medical use; living cells for medical use; cellular function activating agents for medical purposes; vaccines, reagents for medical use; medical diagnostic reagents.

1 Stem cells for research purposes; stem cells for scientific purposes; chemicals for use in manufacturing pharmaceuticals; reagents for research purposes; reagents for medical research; reagents for scientific purposes; diagnostic reagents for scientific or research use; cell culture reagents for scientific and research use; blood culture media for scientific use.

44 Regenerative medicine services; medical services; stem cell therapy services; cell therapy services; cell therapy services for vascular regeneration and repair; cell therapy services relating to the generation of human vascular reparative cells; cell therapy services relating to the injecting, grafting or implanting of cells into patients; medical services relating to the removal, treatment and processing of cells; medical services relating to the removal, treatment and processing of stem cells; stem cell storage; human cell storage; cultured cell bank services for medical transplantation; medical laboratory services for the analysis of samples taken from patients; medical analysis services; services for the testing of blood; medical services relating to the removal, treatment and processing of human blood.

10 Medical devices; medical apparatus; medical instruments; apparatus for the regeneration of stem cells for medical purposes; medical devices and apparatus for vascular regeneration and repair; medical devices and apparatus for cell therapy; blood testing equipment; blood testing apparatus.

42 Medical and pharmacological research services; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research in the field of cell engineering technology; research in the field of vascular regeneration and repair; research and development of medicines; pharmaceutical drug development services; drug discovery services; development of pharmaceutical preparations and medicines; development of cell therapies; research and development services in the medical field of cell therapy; research and development services in the medical field of vascular regeneration and repair; clinical trials; blood analysis services.

Trademark Events

Jul 4, 2024

Sn Assigned For Sect 66a Appl From Ib

Jul 11, 2024

New Application Office Supplied Data Entered

Jul 11, 2024

Application Filing Receipt Mailed